| Financial Year |
March 31 2023 |
| Monetary Funds |
6,001,830,360.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
154,296,243.76 |
| Accounts Receivable |
2,147,364,686.01 |
| Advances to Suppliers |
1,080,251,458.54 |
| Other Receivables |
1,382,891,294.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,656,646.77 |
| Inventories |
4,700,006,286.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
173,459,059.45 |
| Total Current Assets |
15,640,099,390.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,040,391,353.72 |
| Investment Properties |
92,272,130.33 |
| Fixed Assetes |
3,456,440,343.00 |
| Under-construction Projects |
2,387,166,274.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,710,870,052.62 |
| R&D expenses |
644,808,606.31 |
| Goodwill |
56,833,198.95 |
| Long-Term Deferred and Prepaid Expenses |
84,664,154.85 |
| Deferred Income Tax Assets |
212,101,742.84 |
| Other Non-Current Assets |
1,276,641,391.12 |
| Sub-Total of Non-Current Assets |
11,134,472,547.88 |
| Total Assets |
26,774,571,937.99 |
| Short-Term Loans |
110,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
561,394,192.11 |
| Accounts Received In Advance |
5,499,262.33 |
| Employee Compensation Payable |
496,415,801.47 |
| Taxes Payable |
292,212,921.17 |
| Interest Payable |
-- |
| Dividend Payable |
61,419.32 |
| Other payables |
1,233,468,327.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
133,392,757.78 |
| Other Current Liabilities |
259,675,283.36 |
| Sub-Total of Current Liabilities |
3,682,941,919.39 |
| Long-term Loans |
634,986,172.98 |
| Bonds Payable |
450,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
307,037.50 |
| Deferred Income Tax Liabilities |
139,603,098.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,397,682,510.82 |
| Total Liabilities |
5,080,624,430.21 |
| Paid-In Capital(Or Share Stock) |
404,709,790.00 |
| Capital Surplus |
3,431,428,922.62 |
| Surplus Reserve |
1,512,860,413.31 |
| LESS:Treasury Stock |
597,441,037.26 |
| Undistributed Profits |
14,243,659,630.43 |
| Minority Stockholder's Interest |
2,762,702,885.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,931,244,621.84 |
| Owner's Equity（Stockholder's Equity） |
21,693,947,507.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,774,571,937.99 |
